The phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway is known to be frequently activated in several types of cancer and is essential for cancer cell survival, proliferation, angiogenesis, and resistance to chemotherapy [5–6]. Here, AKT1 is linked to cancer.